Silence Therapeutics (SLNCF) Receivables (2019 - 2025)
Historic Receivables for Silence Therapeutics (SLNCF) over the last 7 years, with Q3 2025 value amounting to $28000.0.
- Silence Therapeutics' Receivables fell 9251.73% to $28000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $28000.0, marking a year-over-year decrease of 9251.73%. This contributed to the annual value of $972000.0 for FY2024, which is 24348.4% up from last year.
- According to the latest figures from Q3 2025, Silence Therapeutics' Receivables is $28000.0, which was down 9251.73% from $85000.0 recorded in Q2 2025.
- Silence Therapeutics' Receivables' 5-year high stood at $15.4 million during Q2 2023, with a 5-year trough of $28000.0 in Q3 2025.
- In the last 5 years, Silence Therapeutics' Receivables had a median value of $612205.0 in 2021 and averaged $2.5 million.
- In the last 5 years, Silence Therapeutics' Receivables soared by 49673.97% in 2022 and then crashed by 9960.29% in 2025.
- Over the past 5 years, Silence Therapeutics' Receivables (Quarter) stood at $446191.5 in 2021, then surged by 140.53% to $1.1 million in 2022, then crashed by 73.63% to $282982.6 in 2023, then surged by 243.48% to $972000.0 in 2024, then plummeted by 97.12% to $28000.0 in 2025.
- Its Receivables was $28000.0 in Q3 2025, compared to $85000.0 in Q2 2025 and $41000.0 in Q1 2025.